Recent News, Recalls and Safety Alerts

Senate report links diabetes drug Avandia to heart attacks
(CNN Health, February 21, 2010)
The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released Saturday. Read the article.

FDA Drug Safety Communication on Avandia
(U.S. Food and Drug Admin., February 22, 2010)
FDA notified healthcare professional and patients that it is reviewing the primary data from a large, long-term clinical study on possible cardiovascular risks with the diabetes drug, Avandia. Learn more.

Senate report ties GlaxoSmithKline diabetes drug Avandia to heart attack risks
(The Washington Post, February 21, 2010)
Pharmaceutical giant GlaxoSmithKline knew of possible heart attack risks tied to its controversial diabetes drug Avandia years before evidence of a link became public, according to a U.S. Senate report released Saturday. Read the article.

Toyota Electronics Said to Be a Focus
of U.S. Probe
(Bloomberg.com, February 3, 2010)
Electronic throttle systems are under review by U.S. safety officials as a possible cause of sudden acceleration in Toyota Motor Corp. vehicles, as alleged in at least seven lawsuits. Read the article.

Have you or a loved one
taken Avandia?